FLT3 and acute myeloid leukemia: The FLT3-ITD+ subset (N = 48) among the pediatric AML patients exhibited upregulated FLT3 expression when compared to non-leukemic control samples (N = 74) [Supplementary Figure 6; Supplementary Table 11] as well as FLT3-ITD- pediatric AML cases (N = 189) [Supplementary Figure 7; Supplementary Table 12].